Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

Table 3

Adverse events of the third-line eradication therapy.

	RAL group^†; ( = 24)	RA group^‡; ( = 24)	value
Soft stool/diarrhea, (%)	5 (20.8)	5 (20.8)	n.s.^∗
Nausea, (%)	0 (0)	1 (4.2)	n.s.^∗
Rash, (%)	1 (4.2)	0 (0)	n.s.^∗

RAL group: RPZ 10 mg (b.i.d.), AMPC 750 mg (b.i.d.), and LVFX 500 mg (o.d.).
^‡RA group: RPZ 10 mg (q.i.d.) and AMPC 500 mg (q.i.d.).
^∗Chi-square test.